The Fight Starts Here
A symptom. A test result. A diagnosis. Moments that can change everything for you and for those you love.
American biotech is turning those moments into hope — delivering new options, new treatments, and new answers for the fight ahead.
This Is The Fight
More than 100 million Americans live with a condition that can be treated with biotechnology.
Millions more are still waiting for an option.
| Category | Affected Population |
|---|---|
| Chronic Illness | Over 194 million Americans live with at least one chronic illness. |
| Rare Diseases | Approximately one out of every 10 Americans is affected by an estimated 10,000+ rare diseases. |
| Cancer | Over 18 million Americans have a history of cancer. |
| Autoimmune Diseases | 15 million people in the U.S. are affected by autoimmune diseases. |
| Infectious Diseases | About 23 million Americans seek treatment for infections every year. |
The Power of Biotech
Patients. Families. Researchers. Entrepreneurs.
These are the true stories of the individuals in the fight — and how American biotechnology is improving lives.
50+ Years of Scientific Discovery
50+ Years of Scientific Discovery
1976
America’s First Biotech Company Founding
The company was the first to commercialize recombinant DNA technology. This breakthrough laid the foundation for the modern biotech industry.
1982
FDA Approves the First Biotechnology Drug
This milestone enabled the mass production of synthetic, human-identical insulin using genetically modified E. coli, offering a purer, more reliable supply for diabetics.
2016
Congress Enacts 21st Century Cures Act
This significantly increased funding for biomedical research, including NIH initiatives, and accelerated drug development and clinical trial designs.
Biotech Strengthens Our Economy
Biotech is building hope for patients while powering economies across the U.S.